Skip to main content
AAN.com
Articles
January 11, 2000

A locus for paroxysmal kinesigenic dyskinesia maps to human chromosome 16

January 11, 2000 issue
54 (1) 125

Abstract

Objective: To use genetic linkage analysis to localize a gene for paroxysmal kinesigenic dyskinesia (PKD) in a three generation African-American kindred.
Background: PKD is a rare autosomal dominant disorder characterized by episodic choreiform or dystonic movements that are brought on or exacerbated by voluntary movement. There are individuals with the clinical features of PKD but with no family history of the disease, but whether these sporadic cases represent spontaneous mutations of PKD or have a distinct condition is unknown.
Methods: A genome-wide linkage scan of polymorphic microsatellites at 25 cM resolution was performed to localize a gene for PKD in one African-American kindred. Pairwise multipoint linkage analyses were performed at different penetrance estimates.
Results: Evidence for linkage of the kinesigenic form of paroxysmal dyskinesia to chromosome 16 was obtained. A maximum lod score of 4.40 at θ = 0 was obtained with D16S419. Critical recombinants place the PKD gene between D16S3100 and D16S771.
Conclusions: A paroxysmal kinesigenic dyskinesia (PKD) locus lies within an 18 cM interval on 16p11.2-q11.2, between D16S3100 and D16S771. A gene for infantile convulsions with paroxysmal choreoathetosis has also been mapped to this region. These two regions overlap by approximately 6 cM. These two diseases could be caused by different mutations in the same gene or two distinct genes may lie within this region.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Goodenough D, Fariello R, Annis B, Chun R. Familial and acquired paroxysmal dyskinesias. A proposed classification with delineation of clinical features. Arch Neurol 1978;35:827–831.
2.
Hudgins RL, Corbin KB. An uncommon seizure disorder: familial paroxysmal choreoathetosis. Brain 1966;89:199–204.
3.
Jung SS, Chen KM, Brody JA. Paroxysmal choreoathetosis. Report of Chinese cases. Neurology 1973;23:749–755.
4.
Whitty CWM, Lishman WA, Fitzgibbon JP. Seizures induced by movement. A form of reflex epilepsy. Lancet 1964;1:1403–1406.
5.
Fuchs U, Junkers B. Choreoathetotic seizures. Nervenarzt 1973;44:300–303.
6.
Kato M, Araki S. Paroxysmal kinesigenic choreoathetosis. Report of a case relieved by carbamazepine. Arch Neurol 1969;20:508–513.
7.
Kertesz A. Paroxysmal kinesigenic choreoathetosis. An entity with the paroxysmal kinesigenic choreoathetosis syndrome. Description of 10 cases including 1 autopsied. Neurology (Minneap) 1967;17:680–690.
8.
Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995;38:571–579.
9.
Lance JW. Sporadic and familial varieties of tonic seizures. J Neurol Neurosurg Psychiatry 1963;26:51–59.
10.
Miley CE, Forster FM. Paroxysmal signs and symptoms in multiple sclerosis. Neurology 1974;24:458–461.
11.
Fink JK, Rainier S, Wilkowski J, et al. Paroxysmal dystonic choreoathetosis: Tight linkage to chromosome 2q. Am J Hum Genet 1996;59:140–145.
12.
Fouad GT, Servidei S, Durcan S, Bertini E, Ptacek LJ. A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q. Am J Hum Genet 1996;59:135–139.
13.
Auburger G, Ratzlaff T, Lunkes A, et al. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 1996;31:90–94.
14.
Leube B, Kessler K, Knapp M, Benecke R, Auburger G. Sporadic focal dystonia in Northwest Germany: Molecular basis on chromosome 18p. Ann Neurol 1997;42:111–114.
15.
Szepetowski P, Rochette J, Berquin P, Puissan C, Lathrop GM, Monaco AP. Familial infantile convulsions and paroxysmal choreoathetosis: A new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet 1997;61:889–898.
16.
Lee W-L, Tay A, Ong H-T, Goh L-M, Monaco AP, Szepetowski P. Association of infantile convulsions with paroxysmal dyskinesias (ICCA syndrome): Confirmation of linkage to human chromosome 16p12–q12 in a Chinese family. Hum Genet 1998;103:608–612.
17.
Feder J, Yen L, Wijsman E, et al. A systematic approach for detecting high frequency restriction fragment length polymorphisms using large genomic probes. Am J Hum Genet 1985;37:635–649.
18.
Schaffer A, Gupta S, Shriram K, Cottingham RJ. Avoiding recomputation in linkage analysis. Hum Hered 1994;44:225–237.
19.
Lathrop G, Lalouel J, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 1984;81:3443–3446.
20.
Tan L, Tan A, Tjia H. Paroxysmal kinesigenic choreoathetosis in Singapore and its relationship to epilepsy. Clin Neurol Neurosurg 1998;100:187–192.
21.
Wein T, Anderman F, Silver K, et al. Exquisite sensitivity of paroxysmal kinesigenic choreoathetosis to carbamazepine. Neurology 1996;47:1104–1106.
22.
Ptacek L. Channelopathies: Ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system. Neuromuscul Disord 1996;7:250–255.
23.
Doyle J, Stubbs L. Ataxia, arrhythmia and ion-channel gene defects. Trends Genet 1998;14:92–98.
24.
Bulman D. Phenotype variation and newcomers in ion channel disorders. Hum Mol Genet 1997;6:1679–1685.
25.
Von Brederlow B, Hahn AF, Koopman WJ, Ebers GC, Bulman DE. Mapping the gene for acetazolamide responsive hereditary paroxysmal cerebellar ataxia to chromosome 19p. Hum Mol Genet 1995;4:279–284.
26.
Teh BT, Silburn P, Lindblad K, et al. Familial periodic cerebellar ataxia without mykomia maps to a 19-cM region on 19p13. Am J Hum Genet 1995;56:1443–1449.
27.
Vahedi K, Joutel A, Van Bogaert P, et al. A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann Neurol 1995;37:289–293.
28.
Browne D, Gancher S, Nutt J, et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene KCNA1. Nat Genet 1994;8:136–140.
29.
Litt M, Kramer P, Browne D, et al. A gene for episodic ataxia/myokypia maps to chromosome 12p13. Am J Hum Genet 1994;55:702–709.
30.
Rojas C, Wang J, Schwartz L, Hoffman E, Powell B, Brown R. A Met-to-Val mutation in the skeletal Na+ channel alpha-subunit in hyperkalaemic periodic paralysis. Nature 1991;354:387–389.
31.
McClatchey A, McKenna-Yasek D, Cros D, et al. Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel. Nat Genet 1992;2:148–152.
32.
Ptacek L, Tawil R, Griggs R, et al. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita and hyperkalemic periodic paralysis. Neurology 1994;44:1500–1503.
33.
Fontaine B, Vale-Santos J, Jurkat-Rott K, et al. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31–32 in three European families. Nat Genet 1994;6:267–272.
34.
Jurkat-Rott K, Lehmann-Horn F, Elbaz A, et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 1994;3:1415–1419.
35.
Voilley N, Bassilana F, Mignon C, et al. Cloning, chromosomal localization and physical linkage of the β and γ subunits (SCNN1B and SCNN1G) of the human epithelial amiloride-sensitive sodium channel. Genomics 1995;28:560–565.
36.
Wells R, Mohandas T, Hediger M. Localization of the Na+/glucose transporter gene SGLT2 to human chromosome 16 close to the centromere. Genomics 1993;17:787–789.
37.
Urade Y, Oberdick J, Molinar-Rode R, Morgan JI. Precerebellin is a cerebellum-specific protein with similarity to the glob-ular domain of complement C1q B chain. Proc Natl Acad Sci USA 1991;88:1069–1073.
38.
Pacholczyk T, Blakely RD, Amara SG. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 1991;350:350–354.
39.
Lerner TJ, Boustany RN, Anderson JW, et al. Isolation of novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium. Cell 1995;82:949–957.

Information & Authors

Information

Published In

Neurology®
Volume 54Number 1January 11, 2000
Pages: 125
PubMed: 10636137

Publication History

Received: July 14, 1999
Accepted: October 29, 1999
Published online: January 11, 2000
Published in print: January 11, 2000

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Lynda B. Bennett, PhD
From the Departments of Internal Medicine (Drs. Bennett and Bowcock) and Neurology (Dr. Roach)University of Texas Southwestern Medical Center, Dallas, TX.
E. Steve Roach, MD
From the Departments of Internal Medicine (Drs. Bennett and Bowcock) and Neurology (Dr. Roach)University of Texas Southwestern Medical Center, Dallas, TX.
Anne M. Bowcock, PhD
From the Departments of Internal Medicine (Drs. Bennett and Bowcock) and Neurology (Dr. Roach)University of Texas Southwestern Medical Center, Dallas, TX.

Notes

Address correspondence and reprint requests to Dr. Anne M. Bowcock, Departments of Genetics and Pediatrics, Washington University School of Medicine, Box 8232, 4566 Scott Avenue, St. Louis, MO 63110; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Translating Genetic Discovery into a Mechanistic Understanding of Pediatric Movement Disorders: Lessons from Genetic Dystonias and Related Disorders, Advanced Genetics, 4, 2, (2022).https://doi.org/10.1002/ggn2.202200018
    Crossref
  2. The Genotype and Phenotype of Proline-Rich Transmembrane Protein 2 Associated Disorders in Chinese Children, Frontiers in Pediatrics, 9, (2021).https://doi.org/10.3389/fped.2021.676616
    Crossref
  3. Familial paroxysmal kinesigenic dyskinesia with a novel missense variant (Arg2866Trp) in NBEA, Journal of Human Genetics, 66, 8, (805-811), (2021).https://doi.org/10.1038/s10038-021-00914-0
    Crossref
  4. Paroxysmal dyskinesias, Principles and Practice of Movement Disorders, (560-578.e13), (2021).https://doi.org/10.1016/B978-0-323-31071-0.00024-X
    Crossref
  5. Clinical overview and phenomenology of movement disorders, Principles and Practice of Movement Disorders, (1-51.e27), (2021).https://doi.org/10.1016/B978-0-323-31071-0.00001-9
    Crossref
  6. Exercise test for patients with new-onset paroxysmal kinesigenic dyskinesia, Neurological Sciences, 42, 11, (4623-4628), (2021).https://doi.org/10.1007/s10072-021-05118-0
    Crossref
  7. Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine, BMC Pediatrics, 19, 1, (2019).https://doi.org/10.1186/s12887-019-1798-7
    Crossref
  8. Clinical Manifestation and PRRT2 Analysis of Korean Patients with Paroxysmal Kinesigenic Dyskinesia, Journal of the korean child neurology society, 25, 4, (221-226), (2017).https://doi.org/10.26815/jkcns.2017.25.4.221
    Crossref
  9. Molecular Genetics of the Paroxysmal Dyskinesias, Encyclopedia of Life Sciences, (1-9), (2017).https://doi.org/10.1002/9780470015902.a0027319
    Crossref
  10. Aberrant transcriptional networks in step-wise neurogenesis of paroxysmal kinesigenic dyskinesia-induced pluripotent stem cells, Oncotarget, 7, 33, (53611-53627), (2016).https://doi.org/10.18632/oncotarget.10680
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share